Browse
Drugs
Categories
Pathways
Drug Reactions
Drug Classification
Drug Targets
Pharmaco-genomics
Pharmaco-metabolomics
Pharmaco-transcriptomics
Pharmaco-proteomics
Search
Chemical Structure
Molecular Weight
Drug & Food Interactions
Target Sequences
Pharmaco-omics
Advanced Search
MS Search
MS/MS Search
GC/MS Search
1D NMR Search
2D NMR Search
Downloads
Commercial Data
Products
Clinical Drug Data
Scientific Drug Data
Solutions
Drug Discovery
Drug Repurposing
Precision Medicine
Machine Learning
Drug Search
Drug-Drug Interaction Checker
Help
Help Center
Quick Links
Citing DrugBank
DrugBank.ca FAQs
Searching DrugBank
Other Databases
Data Sources
About
About DrugBank.ca
Statistics
Blog
Wishart Research Group
Contact Us
Drugs
Targets
Pathways
Indications
Stage III Cutaneous Melanoma AJCC v7
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB00041
Aldesleukin
1
Recruiting
1
DB00531
Cyclophosphamide
1
Recruiting
1
DB08912
Dabrafenib
1
Active Not Recruiting
2
DB01073
Fludarabine
1
Recruiting
1
DB01611
Hydroxychloroquine
1
Active Not Recruiting
1
DB06186
Ipilimumab
1
Active Not Recruiting
1
DB06186
Ipilimumab
1
Recruiting
1
DB09035
Nivolumab
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Recruiting
1
DB06306
Onalespib
1
Active Not Recruiting
1
DB00740
Riluzole
1
Active Not Recruiting
1
DB06176
Romidepsin
1
Active Not Recruiting
1
DB00398
Sorafenib
1
Active Not Recruiting
1
DB08911
Trametinib
1
Active Not Recruiting
2
DB00041
Aldesleukin
1 / 2
Recruiting
1
DB00531
Cyclophosphamide
1 / 2
Recruiting
1
DB08912
Dabrafenib
1 / 2
Recruiting
1
DB01073
Fludarabine
1 / 2
Recruiting
1
DB05996
Glembatumumab vedotin
1 / 2
Withdrawn
1
DB06186
Ipilimumab
1 / 2
Recruiting
1
DB06186
Ipilimumab
1 / 2
Withdrawn
1
DB12340
Navitoclax
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Withdrawn
1
DB09037
Pembrolizumab
1 / 2
Recruiting
1
DB08911
Trametinib
1 / 2
Recruiting
1
DB00945
Acetylsalicylic acid
2
Recruiting
1
DB08885
Aflibercept
2
Completed
1
DB00041
Aldesleukin
2
Completed
1
DB11791
Capmatinib
2
Completed
1
DB09063
Ceritinib
2
Completed
1
DB08912
Dabrafenib
2
Active Not Recruiting
1
DB08912
Dabrafenib
2
Recruiting
1
DB11986
Entrectinib
2
Completed
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Recruiting
2
DB09035
Nivolumab
2
Recruiting
2
DB09037
Pembrolizumab
2
Recruiting
2
DB15185
Rasdegafusp alfa
2
Active Not Recruiting
1
DB08896
Regorafenib
2
Completed
1
DB05386
Regramostim
2
Recruiting
1
DB00020
Sargramostim
2
Active Not Recruiting
1
DB13896
Talimogene laherparepvec
2
Recruiting
1
DB08911
Trametinib
2
Active Not Recruiting
1
DB08911
Trametinib
2
Recruiting
1
DB06186
Ipilimumab
2 / 3
Suspended
1
DB09035
Nivolumab
2 / 3
Suspended
1
DB00020
Sargramostim
2 / 3
Suspended
1
DB08912
Dabrafenib
3
Recruiting
1
DB05258
Interferon alfa
3
Active Not Recruiting
1
DB00105
Interferon alfa-2b
3
Active Not Recruiting
1
DB06186
Ipilimumab
3
Active Not Recruiting
1
DB06186
Ipilimumab
3
Recruiting
1
DB09035
Nivolumab
3
Recruiting
1
DB09037
Pembrolizumab
3
Active Not Recruiting
1
DB08911
Trametinib
3
Recruiting
1